TheStreet: Stock Quotes, Financial Market News, & Investment Advice

Vote in our Poll

Who Will Win the Chocolate War?

Will Cadbury, Kraft, Hershey's -- or the chocolatier pairing of Hershey's and Ferrero -- prevail in the battle for Cadbury? Take our poll to see what TheStreet says.

Most Commented Story Today

Biotech Stock Mailbag: FDA Playbook

Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.

Videos

Cheap Oil Stocks

Tim Guinness, portfolio manager for the Guinness Atkinson Global Energy Fund, says oil prices will remain range bound, European oil producers are cheap and natural gas stocks are a smart alternative.

Videos

3D Computers Coming Of Age

Contributor Gary Krakow gets a demonstration of Nvidia's new 3D computer technology by donning the special glasses and watching what could be the future of gaming and entertainment computing.

Videos

International Trade to Turn Up

John Maccarone, CEO of container leasing company Textainer Group, says he expects international trade to increase in 2010 as the economy recovers.

Commentary

Green U.S. Jobs to Come From China

Two recent announcements may herald a new trend: Chinese alternative energy companies setting up plants in the U.S.

Stanley Bing

Back Off, Santa

Stanley Bing wishes retailers would leave Christmas alone and let it start when it usually does.

Best in Class Business

ClickSoftware Offers Value Amid the Bust: Best in Class

ClickSoftware Technologies appears to be in the right place at the right time, as companies are being forced to do more with less.

Between the Lines
Banks & Insurers
Citigroup Worst of Bank Stocks, Poll Says

TheStreet.com's readers view Citigroup as the worst among banks stocks, according to a new poll.

Technology
Cloud Peak Slips Amid Mixed Bag for IPOs

Cloud Peak Energy, Archipelago Learning and Global Defense Technology are enjoying mixed fortunes on their IPO debuts.

Biotech
Biotech Stock Mailbag: FDA Playbook

Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.

ETFs
Don Dion's Weekly ETF Blog Wrap

Here is some of what Don Dion was blogging about the past week on RealMoney.

Earnings
Homebuilder Losers: Horton Hears a Boo

D.R. Horton's weak earnings sent shares of homebuilders tumbling all day, wiping out much of the gains racked up in the sector since Toll Brothers reported positive numbers two weeks ago.

IPOs
IPO Watch: Offerings Rake in $890 Million

Five IPOs, in all, came to market this week, totaling $890 million.

Mergers & Acquisitions
GE, Vivendi Differ on Value of NBCU Stake

General Electric and Vivendi are at least $1 billion apart in their valuation of the French media company's stake in NBC Universal, a report says.

TheStreet Ratings
Five Mid-Cap Stocks Ready to Run

Church & Dwight, Tyler Technologies, Check Point Software and Balchem are rated 'buy' by TheStreet.com.

Winners & Losers
'Fast Money' Recap: Turkey Trades

The trading panel discussed what trades they would make during a holiday-shortened week.

Try RealMoney Free Trial Now

Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,318.16 1,091.38 2,146.04 33.56
Oil *
77.53
DOWN
14.28
DOWN
3.52
DOWN
10.78
UP
0.07
10 Yr
3.36%
SPDR Gold
112.94
-0.14%
-0.32%
-0.50%
+0.21%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services